Banned Substance
benzfetamine
Safety score · 0–100
Not Rated
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
A benzyl-substituted methamphetamine prodrug, prescribed as an anorectic (Didrex). Controlled and prohibited in cosmetics in the EU.
Benzfetamine (benzphetamine, CAS 156-08-1) is an anorectic sympathomimetic that acts as a prodrug to methamphetamine and amphetamine. It is a Schedule IV controlled substance under the US DEA schedule and is prohibited in cosmetic products under EU Regulation (EC) No 1223/2009 Annex II. Pharmacology includes tachycardia, hypertension, insomnia, and dependence liability; there is no topical or cosmetic indication. Its appearance in a cosmetic ingredient registry is exclusively as an Annex II prohibition marker.
Skin benefits
- No legitimate cosmetic use — controlled stimulant
Known concerns
- US DEA Schedule IV
- Metabolises to methamphetamine/amphetamine
- EU Annex II cosmetic ban
- Sympathomimetic cardiovascular effects
- No cosmetic indication
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related banned substances
Check your shelf
Find benzfetamine in your products.
Scan any cosmetic product with LuxSense to see if it contains benzfetamine and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.